Across TCGA pan-cancer cohorts, ZNF649 mass-spec protein differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of ZNF649’s most consistent transcriptional readouts.

The strongest signal is observed in lung squamous cell carcinoma (LSCC), where ZNF649 mass-spec protein is more highly expressed in tumor relative to normal tissue. In most cancer types ZNF649 is over-expressed in tumor, although a few such as HNSC show the opposite, repressed pattern.

LSCC and HNSC are the cancer types where ZNF649 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ZNF649 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LSCC	All	All	+0.336	.001	4	view →
HNSC	All	All	−0.382	.008	3	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: ZNF649 RNA expression & survival · all ZNF649 data types